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osting by EAbstract A stent fracture is an emerging complication of the coronary stents. There are numerous
risk factors for stent fractures; which include forceful exaggerated motion in the atrioventricular
groove seen in right coronary artery, long stent, an ostial lesion at the point of maximum curvature
in a tortuous vessel, stent over-expansion, stent overlapping with different size stents, complex
lesion after stenting of a totally occluded vessel, Cypher stent and a highly mobile segment causing
high mechanical stress. Furthermore, chronic stretch at speciﬁc vessel sites as bends may lead to late
occurrence of fracture.
Here we report a case of 40-year-old male who had two overlapping Cypher stents (3.0 · 13 mm
and 2.75 · 18 mm) deployed at mid left anterior descending artery 2 years earlier presented with
progressive chest pain.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
While the incidence of drug-eluting stent (DES) fracture may
be low, it is a clinically important entity and appears to be
associated with an increased risk for stent thrombosis, myocar-
dial infarction, and angina. Cypher stents appear to be associ-
ated with stent fracture at a higher rate than other DES
(Chhatriwalla et al., 2009). Several cases of DES fractures have
been described and suggested as one of the potentially seriousd.sa (A. Almoghairi).
y. Production and hosting by
Saud University.
lseviercomplications of coronary intervention with DES (Aoki et al.,
2007; Lee et al., 2007; Park et al., 2007; Shite et al., 2006),
although DES fractures reported frequently in long coronary
lesions (Aoki et al., 2007). Data about the incidence, predic-
tors, and outcomes of DES fractures were limited in selected
patients group with long coronary disease.
Stent fracture is considered as a potential mechanism of
restenosis after SES implantation (Sianos et al., 2004).
We report a case of delayed stent fracture after percutane-
ous coronary intervention (PCI) with SES.2. Case report
A 40-year-old man, a cigarette smoker, with hypertension and
dyslipidaemia presented with dyspnoea and angina on mild ef-
fort with pre-syncopal episodes on two occasions. He had pri-
mary PCI to the mid portion of left anterior descending artery
(LAD) for acute anterior myocardial infarction with two over-
lapping Cypher stents (3.0 · 13 mm and 2.75 · 18 mm)
deployed at 12 atmospheric pressure then post dilated with
Figure 1 Left coronary angiography showing ﬁnal result after
LAD stenting.
Figure 3 Stent boost image revealed a strut fracture of mid
portion of the distal stent (arrow).
250 R.N. Eldin et al.3 · 12 mm balloon to 16 atmospheric pressure on 5th of July
2008 (Fig. 1). An ECG showed Q-wave and T-wave inversion
in V2–V6. Echocardiography revealed akinetic anterior and
anterior apical wall with an ejection fraction of 35% and mild
to moderate mitral regurgitation. His medications include;
Aspirin 81 mg daily, Clopidogrel 75 mg daily, Fosinopril
5 mg daily, Carvedilol 6.25 mg twice daily, furosemide 40 mg
daily and spironolactone.
Coronary angiogram showed a fracture of LAD stent with
ﬁlling defect likely represents stent thrombosis (Fig. 2).Figure 2 Left coronary angiography showing LAD stent occlu-
sion (arrow).Intravascular ultrasound (IVUS) revealed well opposed stents
with loss of stent integrity which was conﬁrmed by stent boost
that revealed a strut fracture of mid portion of the distal stent
(Fig. 3). The decision was made to perform PCI where resolute
integrity stent (Medtronic, Inc.) 3.0 · 26 mm deployed distally
and 3.0 · 18 mm proximally with overlap with good ﬁnal result
(Fig. 4). He was discharged home after uneventful hospital
course.
3. Discussion
Current registries published the incidences of DES fracture
ranging from 1.7% to 2.6% (Aoki et al., 2007; Lee et al.,
2007). Usually, stent fracture occurred in long stent implanted
with a larger balloon at high pressure or overlapping site ofFigure 4 Left coronary angiography showing ﬁnal result after
LAD intervention.
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ciﬁed lesions (Sianos et al., 2004). However, in selected lesions
treated with long SES, the incidence of fracture was relatively
common compared with PES (2.9% vs. 0.5%). This ﬁnding led
to suggestion about the possible association of stent structure
with fracture (Lee et al., 2007). The factors that predispose to
stent fracture are long stent, vein graft, or the RCA lesion,
where the lesion location at the RCA increased the risk of frac-
ture by 8-fold compared with non-RCA (Kim et al., 2009).
Stent fracture is found in 29% of the stented lesions at au-
topsy, which is higher than clinically reported (Nakazawa
et al., 2009). Stent fracture is classiﬁed as isolated strut frac-
tures (type 1, single-strut fracture; type 2, incomplete trans-
verse fracture) and complete fracture (type 3, complete
transverse fracture without displacement; type 4, transverse
fracture with displacement) (Nakazawa et al., 2009).
In our case, Cypher stent was deployed in the LAD which
was not tortious and the post dilation pressure not excessively
high (16 ATM) but stent length and torsional forces just distal
to the region of stent overlap may explain the stent fracture.
The closed cell design and thin interconnecting links of SES
with use of larger balloon for post dilation may explain Stent
Fracture.
Although, the exact mechanisms of delayed strut fracture
are unknown, therefore, the alteration of the structural stent
characteristics by drug carrier vehicle is one of the possible
mechanisms of stent fracture.
An IVUS and stent boost are the two methods used to con-
ﬁrm stent fracture after high suspicion by angiographic image.
Stent boost is an enhanced subtracted image automatically
generated from a single standard acquisition at 15 frames per
second consisting of 2 s without contrast to improve stent visu-
alization with the balloon left in place for motion compensa-
tion of the acquired images.
Stent boost provided superior correlations for stent expan-
sion measured by IVUS compared to quantitative coronary
analysis (Mishell et al., 2007).
Optical coherence tomography (OCT), with its excellent
resolution of 10–15 lm, has been described as conﬁrming the
stent fracture diagnosis, or even detecting cases missed by
angiography (Barlis et al., 2009).
The stent fracture is identiﬁed and successfully treated by
repeat stenting with a different type of stent with a higher
ﬂexibility. The Resolute Integrity DES is considered open cellﬂexible stent and less affected by torsion forces, and long stent
used to cover the entire area where these forces occur at edges
of old stents.
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